Corporate & Background
 Custom Manufacturing
 Business & Products
Businesses
Products
Generic API's
Intermediates
Peptide Building Blocks
Carotenoids (Synthetic) and Nutraceuticals
Future Generics
 Facilities & Strengths
 Ethics & Values
 Regulatory Submissions
 Investors & Financials
 Sustainability
 Careers
 Locations & Contact
 Media Center
 Enquiry
 Home
     Our Nutraceuticals website
      News & Events
 Divi's Labs earns an Income of Rs.366 crores in Q2 of FY12
  Divi's Labs earns a PBT of Rs. 130 crores for Q1 of FY12
  Divi's Labs PAT for Q4 grew by 36% to Rs.175 crores
  Divi's Labs earns an Income of Rs.313 crores for Q3 of FY11
  Divi's Labs earns an Income of Rs.265 crores in Q1
  Divi's Labs earns a PAT of Rs.129 crores for Q4
  Divi's Labs earns an Income of Rs.649 crores for 9M of FY10
  Divi's Labs earns an Income of Rs.445 crores in H1 of FY10
  Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus
  Divi's Labs PAT for 9 months
grows by 21% to Rs.309 crores
  Divi's Labs PAT for Q2 grows by
49% to Rs.135 crores
  Divi's Labs PAT for Q1 grows by
45% to Rs.94 crores
  Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores
  Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores
  Divi's Labs PAT for Q2 grows by 204% to Rs.91 crores
  Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores
  Divi's Labs PAT for FY07
grows by 167% to Rs.186 crores
  Divi's Labs Q3 total income
 grows by 38% to Rs.152 crores
 Divis successful US-FDA inspection for Unit II
  Divi's Labs Q2 total income
 grows by 97% to Rs.165 crores.
  Divi's Labs Q1 total
 income grows by 142% at
 Rs.165 crores
  Divi's Laboratories earns a
 Net of Rs.19 crores
 on an Income of
 Rs.110 Crores in Q3
 Divis labs SEZs cleared
  Divis Laboratories earns a
 PBT of Rs.43 Crores in
 First-Half of FY06
  Divis Laboratories earns a
 total income of Rs.68
 Crores in Q1 of FY06
  Divis Laboratories earns a
 total income of Rs.365
 Crores in FY05
  Divis Laboratories earns a
 Net of Rs.105 Crores in Q3
  Divis Laboratories earns a
 PBT of Rs.45 Crores in
 First-Half of FY05
  Divis Laboratories earns a
 Net of Rs.14 Crores in Q1

Divis manufacture API's for the Generics. As a company Divis understand that sustained development is not possible without respecting to IPR. Divis takes great care to ensure that its product or processes do not infringe valid patents.

Divis is actively involved in developing alternate, patent non-infringing processes for APIs, for the inventors to manage late life cycle and leading generic drug manufacturers.

Product Name Structure
BUPROPION Hbr
BUPROPION HCl

CAS No : 31677-93-7
CAPECITABINE

CAS No : 154361-50-9
CARBIDOPA

CAS No : [28860-95-9]
DESLORATADINE

CAS No: [100643-71-8]
DEXLANSOPRAZOLE /(R)-LANSOPRAZOLE

CAS No [138530-94-6]
DEXTROMETHORPHAN BASE

CAS No [125-71-3]
DEXTROMETHORPHAN HBr

CAS No [6700-34-1] (monohydrate)
DILTIAZEM HCl

CAS No [33286-22-5]
FEXOFENADINE

CAS No [153439-40-8]
FOSPHENYTOIN SODIUM

CAS No 92134-98-0
GABAPENTIN

CAS No [60142-96-3]
IOPAMIDOL

CAS No [60166-93-0]
IRBESARTAN

CAS No [138402-11-6]
LEVETIRACETAM

CAS No : 102767-28-2
LEVODOPA

CAS No : 59-92-7
NABUMETONE

CAS No [42924-53-8]
NAPROXEN

CAS No [22204-53-1]
NAPROXEN SODIUM

CAS No [26159-34-2]
NATEGLINIDE

CAS No : 105816-04-4
NIACIN

CAS No : 59-67-6
PHENYLEPHRINE HCl

CAS No [61-76-7]
PROGUANIL HCl

CAS No [637-32-1]
QUETIAPINE FUMARATE

CAS No [111974-72-2]
RISEDRONATE SODIUM

CAS No [115436-72-1]
SERTRALINE HCl

CAS No [79559-97-0]
SIBUTRAMINE HCl

CAS No [125494-59-9]
TAMSULOSIN HCl

CAS No [106463-17-6]
TELMISARTAN

CAS No [144701-48-4]
TRIPROLIDINE HCl

CAS No [6138-79-0]
VALACYCLOVIR HCl

CAS No [124832-27-5]
VALSARTAN

CAS No [137862-53-4]
VENLAFAXINE HCl

CAS No [99300-78-4]
VERAPAMIL HCl

CAS No [152-11-4]
VIGABATRIN

CAS No [60643-86-9]
ZOLPIDEM TARTRATE

CAS No [99294-93-6]
Disclaimer: Products covered by valid patents are not offered for commercial use.It is the buyers responsibility to ensure the transactions do not infringe any patent rights applicable
top
Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved     Web design london